semaglutide covington WEIGHT LOSS SUPPORT Weight Management with Semaglutide —

Values were normalized to the protein concentration of each cell line (left)

Phase 2 results published in The Lancet (2023) demonstrated dose-dependent body weight reductions of up to approximately 16.9% and meaningful HbA1c improvements at 24 weeks in adults with type 2 diabetes

Always consult a qualified clinician before starting any treatment

References PubChem search: Melanotan I afamelanotide PubMed: Melanotan I afamelanotide alpha-MSH PubMed: MC1R melanocortin peptide analogue Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law